Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV) BMC Ophthalmology Source: Author: | Date: 2025-01-24 08:00:00 Source: Author: | Date: 2025-01-24 08:00:00
Distributed training of foundation models for ophthalmic diagnosis Nature Source: Author: | Date: 2025-01-22 08:00:00 Source: Author: | Date: 2025-01-22 08:00:00
Office-based surgery ‘the way of the future’ in ophthalmology Healio Source: Author: | Date: 2025-01-22 08:00:00 Source: Author: | Date: 2025-01-22 08:00:00
An unusual encounter in ophthalmology: Fronto-Ethemoido-Orbital Osteoma with the art of precise referral and management of PEEK implant infection- A rare case report ScienceDirect.com Source: Author: | Date: 2025-01-17 21:47:00 Source: Author: | Date: 2025-01-17 21:47:00
Catch up on our top 10 podcasts of 2024 Mayo Clinic Source: Author: | Date: 2025-01-17 08:00:00 Source: Author: | Date: 2025-01-17 08:00:00
Tele-ophthalmology as an effective triaging tool for acute ophthalmic concerns Frontiers Source: Author: | Date: 2025-01-13 08:00:00 Source: Author: | Date: 2025-01-13 08:00:00
Growing neuro-ophthalmology division provides care, research and training The Ohio State University Wexner Medical Center Source: Author: | Date: 2025-01-10 05:59:00 Source: Author: | Date: 2025-01-10 05:59:00
Evolution of AI in ophthalmology Healio Source: Author: | Date: 2025-01-09 08:00:00 Source: Author: | Date: 2025-01-09 08:00:00
Machine learning derived retinal pigment score from ophthalmic imaging shows ethnicity is not biology Nature Source: Author: | Date: 2025-01-02 08:00:00 Source: Author: | Date: 2025-01-02 08:00:00

Glaukos Corporation has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its innovative corneal cross-linking therapy, Epioxa (Epi-on). This next-generation treatment is designed for patients with keratoconus and represents a significant advancement…